Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Avalon GloboCare Corp.

Company price
None USD 0.00(0%)
Last update at 2026-11-18T21:11:12.368729Z
Market Cap
3.34M

Momentum Score

…

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.34
Low
4.43
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Avalon GloboCare Corp is a clinical-stage biotechnology company developing cell-based and exosome-derived regenerative and immunotherapy technologies for serious diseases. Long-term growth drivers include advancement of clinical programs, broader adoption of cell and exosome approaches, and progress in manufacturing and regulatory pathways that could support commercialization. Investors may find the company attractive for potential upside from successful trial readouts and platform scalability.

Key investment risks include early-stage clinical and regulatory uncertainty, ongoing capital requirements with potential dilution, complex manufacturing challenges and intense competition in the cell-therapy sector.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.39M
Revenue Per Share
0.12
Gross Profit TTM
0.39M
Debt / Equity
0.00
ROE
-212.54%
Net Debt
-0.10M
ROCE
-173.58%
Diluted EPS TTM
-5.41

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -17.52M -7.90M -16.71M -11.93M -9.09M
Minority interest 0.00M 0.00M 0.00M 0.00M 0.00M
Net income -17.52M -7.90M -16.71M -12.68M -9.23M
Selling general administrative 6.04M 4.11M 5.64M 5.66M 8.22M
Selling and marketing expenses 0.84M 0.24M 1.67M 1.33M 0.33M
Gross profit - 0.27M 0.24M 0.27M 0.41M
Reconciled depreciation 0.16M 0.30M 0.37M 0.47M 0.44M
Ebit -16.06M -5.47M -15.36M -8.35M -8.83M
Ebitda -15.90M -5.17M -15.03M -7.89M -8.39M
Depreciation and amortization 0.16M 0.30M 0.33M 0.47M 0.44M
Operating income -7.59M -4.93M -15.75M -7.44M -8.83M
Other operating expenses 7.59M 6.26M 17.01M 8.65M 10.22M
Interest expense 1.46M 2.44M 1.35M 3.58M 0.20M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -1.46M -2.44M -0.98M -3.58M -0.20M
Income tax expense - - 0.00M 0.75M 0.14M
Total revenue 0.00M 1.33M 1.26M 1.20M 1.39M
Total operating expenses 7.59M 5.20M 15.99M 7.72M 9.25M
Cost of revenue - 1.07M 1.02M 0.93M 0.98M
Total other income expense net -9.93M -2.98M -0.95M -3.14M -0.26M
Net income from continuing ops -17.52M -7.90M -9.57M -11.93M -9.09M
Net income applicable to common shares - - - - -9.09M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 23.40M 20.99M 20.58M 19.75M 10.24M
Intangible assets 2.16M - - - -
Other current assets 0.63M 0.17M 0.16M 0.25M 0.02M
Total liab 14.17M 13.88M 13.21M 8.59M 7.16M
Total stockholder equity 9.23M 7.10M 7.37M 11.16M 3.08M
Deferred long term liab - - - - 0.18M
Other current liab 14.14M 5.83M 4.68M 3.54M 3.85M
Common stock 0.00M 0.00M 0.00M 0.00M 0.01M
Capital stock 27.54M 23.50M 20.00M 9.00M 0.01M
Retained earnings -105.93M -87.67M -79.77M -63.06M -51.13M
Good will 12.81M 0.00M - - -
Other assets - - - 9.38M 0.37M
Cash 0.11M 2.86M 0.29M 1.99M 0.81M
Total current liabilities 14.15M 13.88M 6.76M 3.58M 4.40M
Current deferred revenue - 0.04M 0.01M 0.03M 0.01M
Net debt -0.10M 4.98M 8.22M 2.58M 2.49M
Short term debt 0.01M 7.84M 2.05M 0.01M 0.54M
Short long term debt 0.93M 7.83M 1.93M - 0.39M
Short long term debt total 0.01M 7.84M 8.51M 4.57M 3.30M
Other stockholder equity 87.85M 71.50M 67.36M 65.43M 54.37M
Property plant equipment - - - - 8.04M
Total current assets 1.50M 3.24M 0.68M 2.37M 1.32M
Long term investments 0.00M 10.64M 12.10M 0.49M 0.52M
Net tangible assets - - - - 3.08M
Net receivables 0.76M 0.12M 0.23M 0.13M 0.07M
Long term debt - - 6.45M 4.56M 2.75M
Inventory 0.07M 0.09M - - 0.43M
Accounts payable - - 0.01M - 0.00M
Accumulated other comprehensive income -0.23M -0.23M -0.23M -0.21M -0.16M
Non currrent assets other 6.94M 7.09M 0.45M 16.74M 7.90M
Non current assets total 21.90M 17.75M 19.91M 17.38M 8.92M
Capital lease obligations 0.01M 0.01M 0.13M 0.01M 0.16M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.10M -9.02M -9.05M -0.04M
Change to liabilities - - - - 0.00M
Total cashflows from investing activities 1.05M -0.10M - - -0.07M
Net borrowings 0.50M -0.42M - - 2.55M
Total cash from financing activities 1.40M 7.64M 4.83M 17.26M 5.17M
Change to operating activities - - - - 1.53M
Net income -17.52M -7.90M -16.71M -11.93M -9.09M
Change in cash -2.55M 2.57M -1.71M 1.18M 0.08M
Begin period cash flow 2.66M 0.29M 1.99M 0.81M 0.73M
End period cash flow 0.11M 2.86M 0.29M 1.99M 0.81M
Total cash from operating activities -4.99M -4.97M -6.50M -7.04M -5.02M
Issuance of capital stock 0.78M 6.36M 9.64M 9.74M 2.86M
Depreciation 0.16M 0.30M 0.33M 0.47M 0.44M
Other cashflows from investing activities -13.45M -0.10M - - -
Change to account receivables - 0.13M -0.05M -0.04M -0.03M
Other cashflows from financing activities 0.43M 5.20M 0.07M 18.45M 2.62M
Change to netincome - - - - 2.13M
Capital expenditures 0.00M 0.00M 0.02M 0.00M 0.02M
Change in working capital 1.68M -1.23M -0.04M 0.21M 1.50M
Stock based compensation 1.82M 0.52M 1.18M 1.11M 2.11M
Other non cash items 8.87M 3.34M 8.73M 3.11M -0.05M
Free cash flow -4.58M -4.97M -6.53M -7.04M -5.04M

Peer Comparison*

Sector: Real Estate Industry: Real Estate Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CBRE
CBRE Group Inc Class A
-0.06
0.05%
130.65 38.92 21.37 1.09 4.95 1.28 25.73
BEKE
Ke Holdings Inc
-
-%
18.49 42.90 16.92 0.33 2.33 1.66 24.07
VNNVF
Vonovia SE
-
-%
18.54 - 13.44 3.96 0.83 4.07 -3.05
VTAGY
Vantage Towers AG
-
-%
21.42 42.00 37.59 28.32 3.61 21.19 24.26

Profile*

Avalon GloboCare Corp.

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.

4400 Route 9 South, Freehold, NJ, United States, 07728

732 780 4400

2

Name Title Year Born
Dr. David K. Jin M.D., Ph.D. CEO, Pres & Director 1968
Ms. Luisa Ingargiola Chief Financial Officer 1963
Ms. Meng Li COO, Sec. & Director 1978
Dr. David K. Jin M.D., Ph.D. CEO, President & Director 1968
Ms. Luisa Ingargiola Chief Financial Officer 1967
Ms. Meng Li COO, Chief Marketing Officer & Secretary 1978
Ms. Luisa Ingargiola Chief Financial Officer 1966
Ms. Meng Li COO & Secretary 1978
Ms. Meng Li Interim CEO & COO 1978
Ms. Luisa Ingargiola Chief Financial Officer 1968

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…